February 2012
Volume 53, Issue 2
Free
Genetics  |   February 2012
Interactive Effects of ATOH7 and RFTN1 in Association with Adult-Onset Primary Open-Angle Glaucoma
Author Affiliations & Notes
  • Jian-Huan Chen
    From the Joint Shantou International Eye Center, Shantou University and the Chinese University of Hong Kong, Shantou, China; and
    the Department of Ophthalmology and Visual Sciences, the Chinese University of Hong Kong, Hong Kong, China.
  • Degui Wang
    From the Joint Shantou International Eye Center, Shantou University and the Chinese University of Hong Kong, Shantou, China; and
  • Chukai Huang
    From the Joint Shantou International Eye Center, Shantou University and the Chinese University of Hong Kong, Shantou, China; and
  • Yuqian Zheng
    From the Joint Shantou International Eye Center, Shantou University and the Chinese University of Hong Kong, Shantou, China; and
  • Haoyu Chen
    From the Joint Shantou International Eye Center, Shantou University and the Chinese University of Hong Kong, Shantou, China; and
  • Chi-Pui Pang
    From the Joint Shantou International Eye Center, Shantou University and the Chinese University of Hong Kong, Shantou, China; and
    the Department of Ophthalmology and Visual Sciences, the Chinese University of Hong Kong, Hong Kong, China.
  • Mingzhi Zhang
    From the Joint Shantou International Eye Center, Shantou University and the Chinese University of Hong Kong, Shantou, China; and
  • Corresponding author: Mingzhi Zhang, MD, Joint Shantou International Eye Center, Shantou University and the Chinese University of Hong Kong, North Dongxia Road, Shantou, Guangdong, P.R. China 515041; zmz@jsiec.org
Investigative Ophthalmology & Visual Science February 2012, Vol.53, 779-785. doi:https://doi.org/10.1167/iovs.11-8277
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jian-Huan Chen, Degui Wang, Chukai Huang, Yuqian Zheng, Haoyu Chen, Chi-Pui Pang, Mingzhi Zhang; Interactive Effects of ATOH7 and RFTN1 in Association with Adult-Onset Primary Open-Angle Glaucoma. Invest. Ophthalmol. Vis. Sci. 2012;53(2):779-785. https://doi.org/10.1167/iovs.11-8277.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose.: Genome-wide association studies have shown association of the atonal homolog 7 (ATOH7) and raftlin lipid raft linker 1 (RFTN1) genes with glaucoma-related optic disc parameters. ATOH7 and RFTN1 sequence variations were investigated in patients with primary open-angle glaucoma (POAG) and their relationships with vertical cup-to-disc ratio (VCDR) and central corneal thickness (CCT) were determined.

Methods.: In 289 unrelated controls and 142 patients with adult-onset POAG, including 117 with high-tension glaucoma (HTG) and 25 with normal-tension glaucoma (NTG), the single exon of ATOH7 was sequenced by direct sequencing. Additional single-nucleotide polymorphisms (SNP) at upstream ATOH7 (rs1900004 and rs3858145) and an RFTN1 SNP (rs690037) were genotyped. Quantitative trait and disease associations were analyzed by linear and logistic regression respectively, controlling for sex and age.

Results.: ATOH7 rs61854782 was associated with VCDR (P = 0.004) in controls and RFTN1 rs690037 was associated with CCT in combined POAG (HTG+NTG; P = 0.026). No coding mutation was detected in POAG, and no SNP was associated with POAG (P between 0.441 and 0.996). However, ATOH7 rs3858145 showed significant interaction with RFTN1 rs690037 in NTG and combined POAG (P = 0.026 and 0.013 respectively). ATOH7 rs3858145 GG combined with RFTN1 rs690037 TT conferred risk for glaucoma in HTG, NTG, and combined POAG (odds ratio = 2.11, 8.44, and 2.69, respectively).

Conclusions.: Coding mutations of ATOH7 were unlikely to be involved in POAG. But combination of ATOH7 and RFTN1 SNPs increased risk to POAG, indicating their diversified effects in the complex genetics of glaucoma.

Glaucoma is a heterogeneous group of degenerative optic neuropathies with multifactorial etiology. 1,2 It is one of the leading causes of visual loss and blindness worldwide. 3,4 Primary open angle glaucoma (POAG) is one of the most common forms of glaucoma. 5 7 A series of clinical features have been known as risk factors for POAG, such as a thinner retina nerve fiber layer, elevated intraocular pressure, lower central corneal thickness (CCT), and altered optic disc parameters, especially vertical cup-to-disc ratio (VCDR). There are genetic components in the etiology of POAG, as evident from family, twin, and linkage studies. 8 14 Likewise, glaucoma-related biometric parameters such as VCDR and CCT have also been found to be inheritable. 15 18  
Recent genome wide association studies (GWAS) on quantitative traits have identified genes associated with optic disc parameters including optic disc area, optic cup area, and VCDR. 19 21 Among them, atonal homolog 7 (Drosophila; ATOH7, OMIM 609875; Online Mendelian Inheritance in Man; http://www.ncbi.nlm.nih.gov/Omim/ National Center for Biotechnology Information [NCBI], Bethesda, MD) has been reported to be strongly associated with optic disc area in a GWAS involving Australian and U.K. cohorts. 19 The finding was replicated in a GWAS in the Netherlands and an Asian GWAS. 20,21 ATOH7 spans 1.5 kb at chromosome 10, region q21.3. It is a member of the basic helix-loop-helix (bHLH) protein family with similarity to its Drosophila homolog, which controls photoreceptor development. 22,23 ATOH7 participates in the ontogenesis of the vertebrate retina, 24 and deletion of its remote enhancer can cause nonsyndromic congenital retinal nonattachment. 25 Its links with a glaucoma parameter may be due to its role in retinal ganglion cell development. 
Raftlin lipid linker 1 (RFTN1) showed association with optic cup area in a meta-analysis of GWAS. 19 RFTN1 is located on 3p24.3 and is necessary for the integrity of lipid raft and B-cell response signal transduction. 26 It modulates T-cell receptor signaling and enhances th17-mediated autoimmune responses. 27 RFTN1 has been reported to be associated with Alzheimer's disease, 28 with a likely role in neuronal degeneration. Whether RFTN1 affects the development of POAG remains to be elucidated. 
In this study, we investigated the association of ATOH7 and RFTN1 with POAG in a cohort of Southern Chinese. 
Materials and Methods
Patient Recruitment and Clinical Examination
The study subjects were unrelated and included 142 adult-onset POAG patients and 289 controls recruited at the Joint Shantou International Eye Center in Shantou, a city in South China (Table 1). Both POAG patients and controls received a complete ophthalmic examination. Their highest intraocular pressure (IOP), maximum VCDR, and mean CCT were documented. POAG was defined based on the following criteria: (1) exclusion of secondary causes (e.g., trauma, uveitis, and steroid-induced or exfoliation glaucoma); (2) gonioscopically open anterior chamber angle of Shaffer grade III or IV; (3) characteristic optic disc damage and typical visual field loss by automated perimetry (Humphrey; Carl Zeiss Meditec, Dublin, CA) using the Glaucoma Hemifield test. All the patients with adult-onset POAG had an age at disease onset of 35 years or older; 117 had high-tension glaucoma (HTG; highest IOP, ≥21 mm Hg), and 25 had normal-tension glaucoma (NTG; highest IOP, <21 mm Hg). All controls were ≥50 years of age without a family history or any sign of glaucoma. Their highest IOP was lower than 21 mm Hg, and VCDR was <0.5. Peripheral blood was collected from all participants, and genomic DNA was extracted (Qiamp Blood Kit; Qiagen, Hilden, Germany). 
Table 1.
 
Demographic and Clinical Features of the Study Subjects
Table 1.
 
Demographic and Clinical Features of the Study Subjects
n Female Age (y)* IOP (mmHg)† VCDR† CCT (μm)†
Range Mean ± SD Mean ± SD Mean ± SD Mean ± SD
Control 289 147 50–96 71.2 ± 8.6 13.3 ± 2.9 0.3 ± 0.1 542.2 ± 35.8
HTG 117 25 36–85 59.1 ± 12.6 34.1 ± 10.2 0.8 ± 0.2 537.6 ± 37.4
NTG 25 13 40–85 64.3 ± 12.5 16.8 ± 2.7 0.7 ± 0.2 540.3 ± 27.9
This study was approved by the Ethics Committee of Joint Shantou International Eye Center and was conducted in accordance with the Declaration of Helsinki. Written consent was obtained from each participating subject after an explanation of the nature of the study. 
Sequencing of ATOH7
The whole ATOH7 gene (1.5 kb; Fig. 1) plus the 1.0-kb upstream and 0.5-kb downstream sequences were amplified by polymerase chain reactions (PCR) and sequenced in all the 142 POAG patients and 289 controls by direct sequencing, as previously described. 30 The primers listed in Table 2 were designed using PerlPrimer version 1.1.19, referring to the published gene sequence of ATOH7 in the NCBI Reference Sequence database (http://www.ncbi.nlm.nih.gov). 31  
Figure 1.
 
Linkage disequilibrium of the ATOH7 SNPs in the present study. The single exon of ATOH7 and 20-kb upstream genomic region is shown. The two SNPs in the promoter of ATOH7 form a 104-bp haplotype block, and the other two form another haplotype block of 11 kb, according to the criteria of the confidence intervals, an algorithm proposed by Gabriel et al. 29 Solid line with arrow: transcription direction; dashed line with double arrows: the deletion reported by Ghiasvand et al. 25 causing nonsyndromic congenital retinal nonattachment.
Figure 1.
 
Linkage disequilibrium of the ATOH7 SNPs in the present study. The single exon of ATOH7 and 20-kb upstream genomic region is shown. The two SNPs in the promoter of ATOH7 form a 104-bp haplotype block, and the other two form another haplotype block of 11 kb, according to the criteria of the confidence intervals, an algorithm proposed by Gabriel et al. 29 Solid line with arrow: transcription direction; dashed line with double arrows: the deletion reported by Ghiasvand et al. 25 causing nonsyndromic congenital retinal nonattachment.
Table 2.
 
Primers and PCR Conditions for Sequencing of ATOH7
Table 2.
 
Primers and PCR Conditions for Sequencing of ATOH7
Amplicon Target Primer Sequence MgCl2 (mM) Annealing Temperature (°C) Size (bp)
Forward primer (5′→3′) Reverse Primer (5′→3′)
Promoter AAGGAGTCTCAGGCTTTCCC ATCAACCCATTCACAAGATCC 2 62 1212
Promoter-exon AAAGCTGTCCAAGTACGAGAC CTGATATCTCTTCACTTGCC 2 58 1067
Exon-3′ downstream TACCTTTATTCGCATCATCAGACC AAGGAAATCACTTCCAAAGGCA 2 65 930
SNP Genotyping
Five SNPs, including rs61854782, rs7916697, rs1900004, and rs3858145 in ATOH7, and rs690037 in RFTN1 were genotyped. SNPs rs1900004, rs3858145, and rs690037 were genotyped (TaqMan SNP Genotyping Assay; Applied Biosystems, Inc. [ABI], Foster City, CA) according to the protocol suggested by the manufacturer. SNPs rs61854782 and rs7916697 in the 5′-untranslated region (UTR) of ATOH7 were genotyped by direct sequencing of PCR-amplified DNA. 
Statistical Analysis
The Hardy-Weinberg test of each SNP and linkage disequilibrium (LD) analysis was conducted by using Haploview version 4.2 (http://www.broadinstitute.org/haploview, Broad Institute, Massachusetts Institute of Technology, Cambridge, MA). 32 Linear regression was used to analyze association with quantitative traits (VCDR and CCT). The χ2 test and logistic regression are used for analysis of disease association. 30,33 Regression analysis was implemented by the R statistical language version 2.12.12. Regression P values were further adjusted for sex and age. Permutations (×10,000) were used to correct multiple comparisons. P < 0.05 after correction was considered significant. The effect size ± SE (β ± SE) in linear regression or odds ratio (OR) in logistic regression was calculated for different genetic models (additive, dominant, and recessive models). In regression analysis the homozygous major, heterozygous, and homozygous minor genotypes were code as 0, 1, and 2 for additive models, 0, 1, and 1 or dominant models, and 0, 0, and 1 for recessive models, respectively. Haplotype association was analyzed using UPHASED version 3.1.4. 33  
To assess the relationship between the ATOH7 and RFTN1 in association with POAG, two-locus analysis was performed. In logistic regression of disease association, a full model with the interaction term of SNPs, and a reduced model without the interaction term were compared, to assess the effects of interaction. χ2 tests with df = 1 were used to test whether adding the interaction term would significantly reduce the model deviance. 
Results
Association with VCDR and CCT
All the five SNPs genotyped in the present study showed no deviation from Hardy-Weinberg equilibrium in the control subjects (all P > 0.05). In the control subjects, the ATOH7 SNP rs61854782 showed a significant association in the recessive model of the minor allele G (after adjustment for sex and age, P = 0.004, β ± SE = −0.088 ± 0.030; Table 3). The same allele of rs61854782 showed the effects of reduced VCDR in NTG and combined POAG, but it did not reach statistical significance (β ± SE = −0.315 ± 0.177 , P = 0.092, and β ± SE =−0.316 ± 0.180, P = 0.083, respectively). For the other three ATOH7 SNPs and the RFTN1 SNP rs690037, no significant association with VCDR was observed in either the control or the POAG group (P > 0.05). 
Table 3.
 
Association of ATOH7 and RFTN1 SNPs with VCDR and CCT in Controls and POAG
Table 3.
 
Association of ATOH7 and RFTN1 SNPs with VCDR and CCT in Controls and POAG
SNP Minor Allele Control HTG NTG Combined POAG (HTG + NTG)
β SE P * β SE P * β SE P * β SE P *
VCDR
ATOH7
    rs61854782 C −0.088 0.030 0.004 § −0.011 0.045 0.800† −0.315 0.177 0.092§ −0.316 0.180 0.083§
    rs7916697 T 0.006 0.009 0.497‡ 0.101 0.067 0.139§ 0.076 0.081 0.362‡ 0.089 0.059 0.138§
    rs1900004 T −0.003 0.009 0.762‡ 0.070 0.064 0.276§ 0.058 0.081 0.483‡ 0.065 0.057 0.254§
    rs3858145 G 0.006 0.009 0.499‡ 0.051 0.069 0.462§ 0.054 0.059 0.371† 0.052 0.058 0.372§
RFTN1
    rs690037 C −0.013 0.01 0.201‡ −0.041 0.041 0.324‡ 0.057 0.123 0.651§ −0.039 0.037 0.299‡
CCT
ATOH7
    rs61854782 C −1.041 4.292 0.808§ 8.546 13.88 0.542† 47.62 30.14 0.149† 12.6 11.84 0.292†
    rs7916697 T −4.559 4.364 0.297‡ −5.902 9.514 0.539† 19.61 12.36 0.147† 5.638 16.8 0.739§
    rs1900004 T −7.179 6.404 0.263§ −14.23 11.86 0.238‡ 19.61 12.36 0.147† −6.359 9.629 0.512‡
    rs3858145 G −4.417 6.493 0.497§ −13.81 11.77 0.248‡ 19.61 12.36 0.147† 13.51 17.63 0.447§
RFTN1
    rs690037 C −8.002 5.388 0.139§ 24.44 13.36 0.076‡ 47.24 28.42 0.131‡ 25.66 11.44 0.029
None of the ATOH7 SNPs was associated with CCT in the control or the POAG patients (P > 0.05, Table 3). RFTN1 rs690037 was not associated with CCT in the controls (P > 0.05). The SNP showed effects of increased CCT in HTG, NTG, and combined POAG, but was only significant in combined POAG in the dominant model (β ± SE = 24.44 ± 13.36, P = 0.076; β ± SE = 47.24 ± 28.42, P = 0.131; and β ± SE = 25.66 ± 11.44, P = 0.029, respectively). 
Mutation Screen in ATOH7
No mutations in the coding sequences of ATOH7 were detected in either the HTG or the NTG patients (data not shown). No coding variant was found in the controls. 
Single-Gene Association with POAG
None of the genotype frequencies showed any significant difference between the two sexes. The allele frequencies of the four ATOH7 SNPs were not significantly different between the POAG and control groups (all P > 0.05; Table 4). LD analysis revealed relative strong LD among the four ATOH7 SNPs (D′ ≥ 0.78) in a ∼20-kb range. The two SNPs in the 5′-UTR, rs61854782 and rs7916679, formed a 103-bp LD block, and rs1900004 and rs3858145 formed another 11-kb block. None of the haplotypes of these four ATOH7 SNPs was associated with HTG, NTG, or combined POAG (all P > 0.05; Table 5). 
Table 4.
 
Allelic Association between SNPs in the Current Study and POAG
Table 4.
 
Allelic Association between SNPs in the Current Study and POAG
SNP M/m Minor Allele Frequency OR (95% CI) P *
Control Patients
n % n %
HTG
    ATOH7 rs61854782 A/C 87 15.1 31 13.4 0.87 (0.55–1.35) 0.613
rs7916697 C/T 204 35.3 79 34.1 0.95 (0.69–1.30) 0.800
rs1900004 C/T 202 34.9 75 32.1 0.88 (0.63–1.21) 0.480
rs3858145 A/G 199 34.4 73 31.7 0.89 (0.64–1.23) 0.517
    RFTN1 rs690037 T/C 264 45.7 112 47.9 1.09 (0.81–1.48) 0.625
NTG
    ATOH7 rs61854782 A/C 87 15.1 9 18.0 1.25 (0.55–2.57) 0.726
rs7916697 C/T 204 35.3 17 34.0 0.95 (0.50–1.73) 0.976
rs1900004 C/T 202 34.9 16 32.0 0.88 (0.46–1.61) 0.791
rs3858145 A/G 199 34.4 16 33.3 0.96 (0.50–1.77) 0.996
    RFTN1 rs690037 T/C 264 45.7 23 46.0 1.01 (0.56–1.82) 0.917
Combined POAG (HTG + NTG)
    ATOH7 rs61854782 A/C 87 15.1 40 14.2 0.94 (0.62–1.39) 0.815
rs7916697 C/T 204 35.3 96 34.0 0.95 (0.70–1.28) 0.775
rs1900004 C/T 202 34.9 91 32.0 0.88 (0.65–1.19) 0.441
rs3858145 A/G 199 34.4 89 32.0 0.90 (0.66–1.22) 0.533
    RFTN1 rs690037 T/C 264 45.7 135 47.5 1.08 (0.81–1.43) 0.658
Table 5.
 
Association of ATOH7 Haplotypes with POAG
Table 5.
 
Association of ATOH7 Haplotypes with POAG
Haplotype Frequency P
Control HTG NTG Combined POAG (HTG + NTG) HTG NTG Combined POAG (HTG + NTG)
n % n % n % n %
ACCA 351 60.7 147 64.5 31 64.55 178 64.5 0.400 0.747 0.380
ACCG 6 1.1 0 0.0 1 2.1 2 0.7 0.384 0.564 0.612
ACTA 7 1.3 0 0.0 0 0.0 0 0.0 0.093 0.431 0.064
ACTG 7 1.2 2 0.9 0 0.0 2 0.8 0.674 0.456 0.513
ATCG 6 1.1 1 0.4 0 0.0 1 0.4 0.396 0.498 0.306
ATTA 6 1.0 2 1.0 0 0.0 2 0.8 0.968 0.482 0.823
ATTG 104 18.0 45 19.6 8 16.7 52 18.7 0.755 0.738 0.869
CTCA 4 0.7 3 1.3 0 0.0 3 1.1 0.391 1.000 0.554
CTTA 6 1.1 3 1.2 1 2.1 4 1.4 0.937 0.547 0.768
CTTG 70 12.2 22 9.8 7 14.6 30 10.9 0.412 0.671 0.579
Likewise, the alleles of the RFTN1 rs690037 showed no significant difference in frequency between the POAG and control groups (all P > 0.05; Table 4). 
Gene–Gene Interaction in Association with POAG
In the case–control analysis, comparison between the full and reduced regression models showed that inclusion of interaction between ATOH7 and RFTN1 significantly decreased the model deviance, which thus revealed remarkable interactive effects in POAG associations (Table 6). The most profound interaction in HTG, NTG, and combined POAG was detected, when the additive model of rs3858145 was combined with the dominant model of rs690037 (adjusted P = 0.069, 0.026, and 0.013, respectively; Table 6). As shown in Table 7, in the combined POAG, without genotype combination considered, the ORs for rs3858145 AG and GG and rs690037 combined CT+CC genotypes were 0.86, 0.85, and 1.11, respectively. When interaction was considered, rs3858145 GG combined with rs690037 TT exhibited a high risk (OR = 2.69), whereas rs3858145 AG showed an intermediate risk (OR = 1.83). In contrast, when combined with rs690037 CT or CC, rs3858145 GG showed a low risk (OR = 1.15), AG an intermediate risk (OR = 1.45), and AA a high risk (OR = 2.16), with a frequency of 9.2% higher in the combined POAG compared with the control groups (39.6% vs. 30.4%). Interestingly, similar patterns of two-locus genetic risk were also found in NTG and HTG (Fig. 2). Combined with rs690037 TT, rs3858145 AG showed an intermediate risk, and rs3858145 GG exhibited a high risk when compared to rs3858145 AA. When combined with rs690037 CT or CC, the order of genotypic risk was inverted, with rs3858145 AA exhibiting a high risk, rs3858145 AG an intermediate risk and rs3858145 GG a low risk. In addition, the interactive effects were more evident in NTG compared with those in HTG. 
Table 6.
 
P Values of Interaction between ATOH7 and RFTN1 Genotypes in POAG
Table 6.
 
P Values of Interaction between ATOH7 and RFTN1 Genotypes in POAG
ATOH7 HTG NTG Combined POAG (HTG + NTG)
RFTN1 rs690037 RFTN1 rs690037 RFTN1 rs690037
ADD DOM REC ADD DOM REC ADD DOM REC
rs61854782 ADD 0.767 0.540 0.842 0.050 0.055 0.132 0.570 0.691 0.610
DOM 0.556 0.308 0.896 0.120 0.158 0.153 0.888 0.880 0.683
REC 0.328 0.363 0.749 0.075 0.063 0.737 0.124 0.133 0.665
rs7916697 ADD 0.825 0.317 0.498 0.108 0.099 0.279 0.460 0.124 0.683
DOM 0.762 0.357 0.605 0.122 0.097 0.305 0.373 0.123 0.853
REC 0.982 0.487 0.529 0.301 0.330 0.436 0.829 0.379 0.577
rs1900004 ADD 0.452 0.134 0.727 0.074 0.063 0.266 0.216 0.043 0.907
DOM 0.400 0.173 0.940 0.073 0.045 0.298 0.150 0.041 0.843
REC 0.747 0.273 0.543 0.325 0.361 0.432 0.652 0.231 0.594
rs3858145 ADD 0.364 0.069 0.650 0.033 0.026 0.197 0.113 0.013 0.934
DOM 0.482 0.133 0.643 0.078 0.063 0.265 0.186 0.034 0.928
REC 0.404 0.125 0.793 0.087 0.084 0.334 0.191 0.045 0.970
Table 7.
 
Interaction Analysis between ATOH7 rs3858145 and RFTN1 rs690037 Genotype in Combined POAG (HTG + NTG)
Table 7.
 
Interaction Analysis between ATOH7 rs3858145 and RFTN1 rs690037 Genotype in Combined POAG (HTG + NTG)
A. Genotype Distribution
ATOH7 rs3858145 Genotype RFTN1 rs690037 Genotype
Combined POAG (HTG + NTG) (n = 142) Control (n = 289)
TT CT + CC TT CT + CC
AA 11 7.9% 55 39.6% 38 13.1% 88 30.4%
AG 18 12.9% 39 28.1% 34 11.8% 93 32.2%
GG 7 5.0% 9 6.5% 9 3.1% 27 9.3%
B. Joint ORs and 95% CI
ATOH7 rs3858145 RFTN1 rs690037 Genotype
Main Effects TT CT + CC
OR RFTN1 1 (Ref) 1.11 (0.70–1.76)
OR ATOH7 Joint Effects
AA 1 (Ref) 1 (Ref) 2.16 (1.02–4.57)
AG 0.86 (0.56–1.32) 1.83 (0.76–4.42) 1.45 (0.67–3.12)
GG 0.85 (0.44–1.64) 2.69 (0.81–8.87) 1.15 (0.42–3.16)
Figure 2.
 
Two-locus (ATOH7 and RFTN1) genotype-specific POAG risk. With combination of rs690037 TT/rs3858145 AA as the reference (OR = 1), ORs are calculated for different genotype combinations. (A) Joint effect analysis with rs3858145 genotypes combined with the rs690037 TT genotype and (B) with rs3858145 genotypes combined with the rs690037 CT or CC genotype.
Figure 2.
 
Two-locus (ATOH7 and RFTN1) genotype-specific POAG risk. With combination of rs690037 TT/rs3858145 AA as the reference (OR = 1), ORs are calculated for different genotype combinations. (A) Joint effect analysis with rs3858145 genotypes combined with the rs690037 TT genotype and (B) with rs3858145 genotypes combined with the rs690037 CT or CC genotype.
Discussion
Our results provided evidence for interactive effects of ATOH7 and RFTN1 polymorphisms that resulted in increased risk to POAG. Either gene alone, however, did not significantly contribute to risk for POAG in the Southern Chinese population. 
In a GWAS, SNPs rs3858145, rs1900004, and rs7916697 in ATOH7 were significantly associated with optic disc area. 19 SNP rs3858145 was associated with optic cup area in a meta-analysis of Australian and U.K. cohorts. The association of ATOH7 with optic disc area was also found in GWAS in the Netherlands 20 and in Asian populations. 21 With respect to VCDR association, inconsistent findings were reported. The most significant association was reported at rs190004 by the Netherlands GWAS. However, none of these three SNPs was associated with VCDR in Asians 21 or American Caucasians. 14 In the present study in the Chinese, no significant association was observed between these three SNPs and VCDR. All these SNPs showed a low β with a relatively large SE in association analysis of VCDR (|β| ≤ 0.006). Instead, significant association was found in controls and possibly in POAG at another SNP rs61854782 located at an ATOH7 5′-UTR, 104 bp downstream of rs7916697. It had a lower minor allele frequency compared with the other three ATOH7 SNPs (15.1% in controls) and exerted a much larger effect of 0.088 reduction on VCDR in controls. Furthermore, rs61854782 was in high LD with the other three ATOH7 SNPs, suggesting that it probably is the true VCDR-associated SNP in ATOH7. Although this SNP has been detected in Australian GWAS, its effects on optic disc parameters had not been investigated. This is the first report thus far of the association of this ATOH7 SNP with VCDR. 
ATOH7 is a highly conserved gene, sharing high similarity to its Drosophila homolog. 22 ATOH7 mutations have been reported in optic nerve hypoplasia. 19 We did not detect any ATOH7 mutation in our Chinese POAG patients. In addition, in an association analysis, all ATOH7 SNPs showed similar allele frequency between the control and POAG groups, with allelic ORs close to 1, suggesting that these SNPs were not associated with POAG. In the GWAS in the Netherlands, ATOH7 was marginally associated with open-angle glaucoma (rs1900004; P = 0.04). However, in a GWAS involving 1,263 POAG patients and 34,877 controls in Iceland that identified caveolin-1 (CAV1) and caveolin-2 (CAV2) as putative POAG susceptibility genes, ATOH7 was not significantly associated with POAG at a genome-wide significance level (P > 10−4). In addition, no association was shown between ATOH7 and POAG in a recent study of American Caucasians. 14  
The role of RFTN1 in neurons remains unclear. However, it has recently been reported to associate with Alzheimer's disease, 28 another degenerative neuronal disease. Interestingly, other lipid-raft molecules have been shown to interact with myocilin (MYOC) and CAV1. 34,35 RFTN1 rs690037 was associated with cup area and VCDR in Australian twin and U.K. cohorts. 19 In our study, the association of rs690037 with VCDR was implicated in the controls. Moreover, in HTG, NTG, and combined POAG rs690037 was associated with CCT. Although no association of rs690037 with POAG was found in our study, these findings still suggest that RFTN1 is a modifier in POAG etiology. Interestingly, the C allele was found to have a lower frequency in our Chinese cohort than in Caucasians (45.7% in our controls vs. 53.5% in the HapMap CEU subjects). 
Results of our gene–gene interaction analysis indicated significant interaction between ATOH7 and RFTN1. The effects of different ATOH7 genotypes could be reverted by combination of different RFTN1 genotypes. This could be an explanation to the absence of single-gene effect when either gene was analyzed separately. Furthermore, in a recent report by Ghiasvand et al., 25 a 6.5-kb deletion located 21.7 to 15.2 kb upstream of the ATOH7 transcription start site, led to nonsyndromic congenital retinal nonattachment. The deletion spanned an evolutionarily conserved, remote secondary enhancer required for normal expression of ATOH7 in neurogenesis. It was noted that the deletion also spanned rs3858145, which probably implicated the possible functional link of this SNP. The rs3858145 T allele was reported to have effects of increased optic disc and cup areas in Australian twin and U.K. cohorts. 19 Furthermore, similar patterns of two-locus genotypic risk were observed in both HTG and NTG compared with combined POAG, underlining a potential common role of the interaction in glaucomatous optic neuropathy. In addition, the interactive effects were more evident in NTG than in HTG. Combination of ATOH7 and RNTN1 genotypes conferred a greater risk for glaucoma in NTG than in HTG. 
In conclusion, our results showed association between ATOH7 and VCDR. There were significant interactive effects of the two optic disc parameter–related genes but no single-gene effect in association with adult-onset POAG in our Chinese cohort. Interaction between the ATOH7 and RFTN1 genotypes conferred risk for POAG. Our findings reflect the complexity and underline the importance of gene–gene interactions in POAG genetics. 
Footnotes
 Supported in part by Research Grants 81000397 from the National Natural Science Foundation of China; 8151503102000019 from the Natural Science Foundation of Guangdong Province, China; 2010B031600130 from the Science and Technology Planning Project of Guangdong Province, China; and 10-020, 10-021, and 10-022 from the Joint Shantou International Eye Center, Shantou University/The Chinese University of Hong Kong.
Footnotes
 Disclosure: J.-H. Chen, None; D. Wang, None; C. Huang, None; Y. Zheng, None; H. Chen, None; C.-P. Pang, None; M. Zhang, None
References
Quigley HA . Open-angle glaucoma. N Engl J Med. 1993;328:1097–1106. [CrossRef] [PubMed]
Quigley HA Enger C Katz J Sommer A Scott R Gilbert D . Risk factors for the development of glaucomatous visual field loss in ocular hypertension. Arch Ophthalmol. 1994;112:644–649. [CrossRef] [PubMed]
Quigley HA Broman AT . The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262–267. [CrossRef] [PubMed]
Resnikoff S Pascolini D Etya'ale D . Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82:844–851. [PubMed]
He M Foster PJ Ge J . Prevalence and clinical characteristics of glaucoma in adult Chinese: a population-based study in Liwan District, Guangzhou. Invest Ophthalmol Vis Sci. 2006;47:2782–2788. [CrossRef] [PubMed]
Xu L Chen JH Li JJ . The prevalence and its screening methods of primary open angle glaucoma in defined population-based study of rural and urban in Beijing (in Chinese). Zhonghua Yan Ke Za Zhi. 2004;40:726–732. [PubMed]
Dandona L Dandona R Srinivas M . Open-angle glaucoma in an urban population in southern India: the Andhra Pradesh eye disease study. Ophthalmology. 2000;107:1702–1709. [CrossRef] [PubMed]
Wang DY Fan BJ Chua JK . A genome-wide scan maps a novel juvenile-onset primary open-angle glaucoma locus to 15q. Invest Ophthalmol Vis Sci. 2006;47:5315–5321. [CrossRef] [PubMed]
Pang CP Fan BJ Canlas O . A genome-wide scan maps a novel juvenile-onset primary open angle glaucoma locus to chromosome 5q. Mol Vis. 2006;12:85–92. [PubMed]
Mitchell P Cumming RG Mackey DA . Inhaled corticosteroids, family history, and risk of glaucoma. Ophthalmology. 1999;106:2301–2306. [CrossRef] [PubMed]
Nemesure B Leske MC He Q Mendell N . Analyses of reported family history of glaucoma: a preliminary investigation. The Barbados Eye Study Group. Ophthalmic Epidemiol. 1996;3:135–141. [CrossRef] [PubMed]
Teikari JM . Genetic factors in open-angle (simple and capsular) glaucoma: a population-based twin study. Acta Ophthalmol (Copenh). 1987;65:715–720. [CrossRef] [PubMed]
Sheffield VC Stone EM Alward WL . Genetic linkage of familial open angle glaucoma to chromosome 1q21–q31. Nat Genet. 1993;4:47–50. [CrossRef] [PubMed]
Fan BJ Wang DY Pasquale LR Haines JL Wiggs JL . Genetic variants associated with optic nerve vertical cup-to-disc ratio are risk factors for primary open angle glaucoma in a US Caucasian population. Invest Ophthalmol Vis Sci. 2011;52:1788–1792. [CrossRef] [PubMed]
Bengtsson B . The inheritance and development of cup and disc diameters. Acta Ophthalmol (Copenh). 1980;58:733–739. [CrossRef] [PubMed]
He M Liu B Huang W . Heritability of optic disc and cup measured by the Heidelberg Retinal Tomography in Chinese: the Guangzhou twin eye study. Invest Ophthalmol Vis Sci. 2008;49:1350–1355. [CrossRef] [PubMed]
Schwartz JT Reuling FH Feinleib M . Size of the physiologic cup of the optic nerve head. hereditary and environmental factors. Arch Ophthalmol. 1975;93:776–778. [CrossRef] [PubMed]
Toh T Liew SH MacKinnon JR . Central corneal thickness is highly heritable: the twin eye studies. Invest Ophthalmol Vis Sci. 2005;46:3718–3722. [CrossRef] [PubMed]
Macgregor S Hewitt AW Hysi PG . Genome-wide association identifies ATOH7 as a major gene determining human optic disc size. Hum Mol Genet. 2010;19:2716–2724. [CrossRef] [PubMed]
Ramdas WD van Koolwijk LM Ikram MK . A genome-wide association study of optic disc parameters. PLoS Genet. 2010;6:e1000978. [CrossRef] [PubMed]
Khor CC Ramdas WD Vithana EN . Genome-wide association studies in Asians confirm the involvement of ATOH7 and TGFBR3, and further identify CARD10 as a novel locus influencing optic disc area. Hum Mol Genet. 2011;20:1864–1872. [CrossRef] [PubMed]
Sun Y Kanekar SL Vetter ML . Conserved and divergent functions of Drosophila atonal, amphibian, and mammalian Ath5 genes. Evol Dev. 2003;5:532–541. [CrossRef] [PubMed]
Brown NL Dagenais SL Chen CM Glaser T . Molecular characterization and mapping of ATOH7, a human atonal homolog with a predicted role in retinal ganglion cell development. Mamm Genome. 2002;13:95–101. [CrossRef] [PubMed]
Skowronska-Krawczyk D Chiodini F Ebeling M . Conserved regulatory sequences in Atoh7 mediate non-conserved regulatory responses in retina ontogenesis. Development. 2009;136:3767–3777. [CrossRef] [PubMed]
Ghiasvand NM Rudolph DD Mashayekhi M Brzezinski JAT Goldman D Glaser T . Deletion of a remote enhancer near ATOH7 disrupts retinal neurogenesis, causing NCRNA disease. Nat Neurosci. 2011;14:578–586. [CrossRef] [PubMed]
Saeki K Miura Y Aki D Kurosaki T Yoshimura A . The B cell-specific major raft protein, Raftlin, is necessary for the integrity of lipid raft and BCR signal transduction. EMBO J. 2003;22:3015–3026. [CrossRef] [PubMed]
Saeki K Fukuyama S Ayada T . A major lipid raft protein raftlin modulates T cell receptor signaling and enhances th17-mediated autoimmune responses. J Immunol. 2009;182:5929–5937. [CrossRef] [PubMed]
Wollmer MA Sleegers K Ingelsson M . Association study of cholesterol-related genes in Alzheimer's disease. Neurogenetics. 2007;8:179–188. [CrossRef] [PubMed]
Gabriel SB Schaffner SF Nguyen H . The structure of haplotype blocks in the human genome. Science. 2002;296:2225–2229. [CrossRef] [PubMed]
Chen J Tsang SY Zhao CY . GABRB2 in schizophrenia and bipolar disorder: disease association, gene expression and clinical correlations. Biochem Soc Trans. 2009;37:1415–1418. [CrossRef] [PubMed]
Marshall OJ . PerlPrimer: cross-platform, graphical primer design for standard, bisulphite and real-time PCR. Bioinformatics. 2004;20:2471–2472. [CrossRef] [PubMed]
Barrett JC Fry B Maller J Daly MJ . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–265. [CrossRef] [PubMed]
Dudbridge F . Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered. 2008;66:87–98. [CrossRef] [PubMed]
Joe MK Sohn S Choi YR Park H Kee C . Identification of flotillin-1 as a protein interacting with myocilin: Implications for the pathogenesis of primary open-angle glaucoma. Biochem Biophys Res Commun. 2005;336:1201–1206. [CrossRef] [PubMed]
Di Vizio D Adam RM Kim J . Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase. Cell Cycle. 2008;7:2257–2267. [CrossRef] [PubMed]
Figure 1.
 
Linkage disequilibrium of the ATOH7 SNPs in the present study. The single exon of ATOH7 and 20-kb upstream genomic region is shown. The two SNPs in the promoter of ATOH7 form a 104-bp haplotype block, and the other two form another haplotype block of 11 kb, according to the criteria of the confidence intervals, an algorithm proposed by Gabriel et al. 29 Solid line with arrow: transcription direction; dashed line with double arrows: the deletion reported by Ghiasvand et al. 25 causing nonsyndromic congenital retinal nonattachment.
Figure 1.
 
Linkage disequilibrium of the ATOH7 SNPs in the present study. The single exon of ATOH7 and 20-kb upstream genomic region is shown. The two SNPs in the promoter of ATOH7 form a 104-bp haplotype block, and the other two form another haplotype block of 11 kb, according to the criteria of the confidence intervals, an algorithm proposed by Gabriel et al. 29 Solid line with arrow: transcription direction; dashed line with double arrows: the deletion reported by Ghiasvand et al. 25 causing nonsyndromic congenital retinal nonattachment.
Figure 2.
 
Two-locus (ATOH7 and RFTN1) genotype-specific POAG risk. With combination of rs690037 TT/rs3858145 AA as the reference (OR = 1), ORs are calculated for different genotype combinations. (A) Joint effect analysis with rs3858145 genotypes combined with the rs690037 TT genotype and (B) with rs3858145 genotypes combined with the rs690037 CT or CC genotype.
Figure 2.
 
Two-locus (ATOH7 and RFTN1) genotype-specific POAG risk. With combination of rs690037 TT/rs3858145 AA as the reference (OR = 1), ORs are calculated for different genotype combinations. (A) Joint effect analysis with rs3858145 genotypes combined with the rs690037 TT genotype and (B) with rs3858145 genotypes combined with the rs690037 CT or CC genotype.
Table 1.
 
Demographic and Clinical Features of the Study Subjects
Table 1.
 
Demographic and Clinical Features of the Study Subjects
n Female Age (y)* IOP (mmHg)† VCDR† CCT (μm)†
Range Mean ± SD Mean ± SD Mean ± SD Mean ± SD
Control 289 147 50–96 71.2 ± 8.6 13.3 ± 2.9 0.3 ± 0.1 542.2 ± 35.8
HTG 117 25 36–85 59.1 ± 12.6 34.1 ± 10.2 0.8 ± 0.2 537.6 ± 37.4
NTG 25 13 40–85 64.3 ± 12.5 16.8 ± 2.7 0.7 ± 0.2 540.3 ± 27.9
Table 2.
 
Primers and PCR Conditions for Sequencing of ATOH7
Table 2.
 
Primers and PCR Conditions for Sequencing of ATOH7
Amplicon Target Primer Sequence MgCl2 (mM) Annealing Temperature (°C) Size (bp)
Forward primer (5′→3′) Reverse Primer (5′→3′)
Promoter AAGGAGTCTCAGGCTTTCCC ATCAACCCATTCACAAGATCC 2 62 1212
Promoter-exon AAAGCTGTCCAAGTACGAGAC CTGATATCTCTTCACTTGCC 2 58 1067
Exon-3′ downstream TACCTTTATTCGCATCATCAGACC AAGGAAATCACTTCCAAAGGCA 2 65 930
Table 3.
 
Association of ATOH7 and RFTN1 SNPs with VCDR and CCT in Controls and POAG
Table 3.
 
Association of ATOH7 and RFTN1 SNPs with VCDR and CCT in Controls and POAG
SNP Minor Allele Control HTG NTG Combined POAG (HTG + NTG)
β SE P * β SE P * β SE P * β SE P *
VCDR
ATOH7
    rs61854782 C −0.088 0.030 0.004 § −0.011 0.045 0.800† −0.315 0.177 0.092§ −0.316 0.180 0.083§
    rs7916697 T 0.006 0.009 0.497‡ 0.101 0.067 0.139§ 0.076 0.081 0.362‡ 0.089 0.059 0.138§
    rs1900004 T −0.003 0.009 0.762‡ 0.070 0.064 0.276§ 0.058 0.081 0.483‡ 0.065 0.057 0.254§
    rs3858145 G 0.006 0.009 0.499‡ 0.051 0.069 0.462§ 0.054 0.059 0.371† 0.052 0.058 0.372§
RFTN1
    rs690037 C −0.013 0.01 0.201‡ −0.041 0.041 0.324‡ 0.057 0.123 0.651§ −0.039 0.037 0.299‡
CCT
ATOH7
    rs61854782 C −1.041 4.292 0.808§ 8.546 13.88 0.542† 47.62 30.14 0.149† 12.6 11.84 0.292†
    rs7916697 T −4.559 4.364 0.297‡ −5.902 9.514 0.539† 19.61 12.36 0.147† 5.638 16.8 0.739§
    rs1900004 T −7.179 6.404 0.263§ −14.23 11.86 0.238‡ 19.61 12.36 0.147† −6.359 9.629 0.512‡
    rs3858145 G −4.417 6.493 0.497§ −13.81 11.77 0.248‡ 19.61 12.36 0.147† 13.51 17.63 0.447§
RFTN1
    rs690037 C −8.002 5.388 0.139§ 24.44 13.36 0.076‡ 47.24 28.42 0.131‡ 25.66 11.44 0.029
Table 4.
 
Allelic Association between SNPs in the Current Study and POAG
Table 4.
 
Allelic Association between SNPs in the Current Study and POAG
SNP M/m Minor Allele Frequency OR (95% CI) P *
Control Patients
n % n %
HTG
    ATOH7 rs61854782 A/C 87 15.1 31 13.4 0.87 (0.55–1.35) 0.613
rs7916697 C/T 204 35.3 79 34.1 0.95 (0.69–1.30) 0.800
rs1900004 C/T 202 34.9 75 32.1 0.88 (0.63–1.21) 0.480
rs3858145 A/G 199 34.4 73 31.7 0.89 (0.64–1.23) 0.517
    RFTN1 rs690037 T/C 264 45.7 112 47.9 1.09 (0.81–1.48) 0.625
NTG
    ATOH7 rs61854782 A/C 87 15.1 9 18.0 1.25 (0.55–2.57) 0.726
rs7916697 C/T 204 35.3 17 34.0 0.95 (0.50–1.73) 0.976
rs1900004 C/T 202 34.9 16 32.0 0.88 (0.46–1.61) 0.791
rs3858145 A/G 199 34.4 16 33.3 0.96 (0.50–1.77) 0.996
    RFTN1 rs690037 T/C 264 45.7 23 46.0 1.01 (0.56–1.82) 0.917
Combined POAG (HTG + NTG)
    ATOH7 rs61854782 A/C 87 15.1 40 14.2 0.94 (0.62–1.39) 0.815
rs7916697 C/T 204 35.3 96 34.0 0.95 (0.70–1.28) 0.775
rs1900004 C/T 202 34.9 91 32.0 0.88 (0.65–1.19) 0.441
rs3858145 A/G 199 34.4 89 32.0 0.90 (0.66–1.22) 0.533
    RFTN1 rs690037 T/C 264 45.7 135 47.5 1.08 (0.81–1.43) 0.658
Table 5.
 
Association of ATOH7 Haplotypes with POAG
Table 5.
 
Association of ATOH7 Haplotypes with POAG
Haplotype Frequency P
Control HTG NTG Combined POAG (HTG + NTG) HTG NTG Combined POAG (HTG + NTG)
n % n % n % n %
ACCA 351 60.7 147 64.5 31 64.55 178 64.5 0.400 0.747 0.380
ACCG 6 1.1 0 0.0 1 2.1 2 0.7 0.384 0.564 0.612
ACTA 7 1.3 0 0.0 0 0.0 0 0.0 0.093 0.431 0.064
ACTG 7 1.2 2 0.9 0 0.0 2 0.8 0.674 0.456 0.513
ATCG 6 1.1 1 0.4 0 0.0 1 0.4 0.396 0.498 0.306
ATTA 6 1.0 2 1.0 0 0.0 2 0.8 0.968 0.482 0.823
ATTG 104 18.0 45 19.6 8 16.7 52 18.7 0.755 0.738 0.869
CTCA 4 0.7 3 1.3 0 0.0 3 1.1 0.391 1.000 0.554
CTTA 6 1.1 3 1.2 1 2.1 4 1.4 0.937 0.547 0.768
CTTG 70 12.2 22 9.8 7 14.6 30 10.9 0.412 0.671 0.579
Table 6.
 
P Values of Interaction between ATOH7 and RFTN1 Genotypes in POAG
Table 6.
 
P Values of Interaction between ATOH7 and RFTN1 Genotypes in POAG
ATOH7 HTG NTG Combined POAG (HTG + NTG)
RFTN1 rs690037 RFTN1 rs690037 RFTN1 rs690037
ADD DOM REC ADD DOM REC ADD DOM REC
rs61854782 ADD 0.767 0.540 0.842 0.050 0.055 0.132 0.570 0.691 0.610
DOM 0.556 0.308 0.896 0.120 0.158 0.153 0.888 0.880 0.683
REC 0.328 0.363 0.749 0.075 0.063 0.737 0.124 0.133 0.665
rs7916697 ADD 0.825 0.317 0.498 0.108 0.099 0.279 0.460 0.124 0.683
DOM 0.762 0.357 0.605 0.122 0.097 0.305 0.373 0.123 0.853
REC 0.982 0.487 0.529 0.301 0.330 0.436 0.829 0.379 0.577
rs1900004 ADD 0.452 0.134 0.727 0.074 0.063 0.266 0.216 0.043 0.907
DOM 0.400 0.173 0.940 0.073 0.045 0.298 0.150 0.041 0.843
REC 0.747 0.273 0.543 0.325 0.361 0.432 0.652 0.231 0.594
rs3858145 ADD 0.364 0.069 0.650 0.033 0.026 0.197 0.113 0.013 0.934
DOM 0.482 0.133 0.643 0.078 0.063 0.265 0.186 0.034 0.928
REC 0.404 0.125 0.793 0.087 0.084 0.334 0.191 0.045 0.970
Table 7.
 
Interaction Analysis between ATOH7 rs3858145 and RFTN1 rs690037 Genotype in Combined POAG (HTG + NTG)
Table 7.
 
Interaction Analysis between ATOH7 rs3858145 and RFTN1 rs690037 Genotype in Combined POAG (HTG + NTG)
A. Genotype Distribution
ATOH7 rs3858145 Genotype RFTN1 rs690037 Genotype
Combined POAG (HTG + NTG) (n = 142) Control (n = 289)
TT CT + CC TT CT + CC
AA 11 7.9% 55 39.6% 38 13.1% 88 30.4%
AG 18 12.9% 39 28.1% 34 11.8% 93 32.2%
GG 7 5.0% 9 6.5% 9 3.1% 27 9.3%
B. Joint ORs and 95% CI
ATOH7 rs3858145 RFTN1 rs690037 Genotype
Main Effects TT CT + CC
OR RFTN1 1 (Ref) 1.11 (0.70–1.76)
OR ATOH7 Joint Effects
AA 1 (Ref) 1 (Ref) 2.16 (1.02–4.57)
AG 0.86 (0.56–1.32) 1.83 (0.76–4.42) 1.45 (0.67–3.12)
GG 0.85 (0.44–1.64) 2.69 (0.81–8.87) 1.15 (0.42–3.16)
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×